Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells

Clinical Lung Cancer

Volumn 9, Issue 6, 2008, Pages 367-374

  Gray, Steven G ^a   Al Sarraf, Nael ^a,b   Baird, Anne Marie ^a   Gately, Kathy ^a   McGovern, Eilish ^b   O'Byrne, Kenneth J ^a,b  

^a Institute of Molecular Medicine   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Acetylation; Chromatin; DNA methylation; Histone

Indexed keywords

HISTONE DEACETYLASE INHIBITOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 5; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; EPIGENETICS; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN ISOLATION; PROTEIN METHYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TISSUE SECTION; TRANSCRIPTION REGULATION;

EID: 59449101956     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2008.n.053     Document Type: Article

References (45)

1. Lee YH, White MF. Insulin receptor substrate proteins and diabetes. Arch Pharm Res 2004; 27:361-70.
2. Bjornholm M, He AR, Attersand A, et al. Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia 2002; 45:1697-702.
3. White MF. IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002; 283:E413-22.
4. Cai D, Dhe-Paganon S, Melendez PA, et al. Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J Biol Chem 2003; 278:25323-30.
5. Favre C, Gerard A, Clauzier E, et al. DOK4 and DOK5: new Dok-related genes expressed in human T cells. Genes Immun 2003; 4:40-5.
6. Al-Sarraf N, Reiff JN, Hinrichsen J, et al. DOK4/IRS-5 expression is altered in clear cell renal cell carcinoma. Int J Cancer 2007; 121:992-8.
7. Bedirian A, Baldwin C, Abe J, et al. Pleckstrin homology and phosphotyrosine- binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells. J Biol Chem 2004; 279:19335-49.
8. Itoh S, Lemay S, Osawa M, et al. Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J Biol Chem 2005; 280:26383-96.
9. Baldwin C, Bedirian A, Li H, et al. Identification of Dok-4b, a Dok-4 splice variant with enhanced inhibitory properties. Biochem Biophys Res Commun 2007; 354:783-8.
10. Karamouzis MV, Papavassiliou AG. The IGF-1 network in lung carcinoma therapeutics. Trends Mol Med 2006; 12:595-602.
11. Hartog H, Wesseling J, Boezen HM, et al. The insulin-like growth factor 1 receptor in cancer: old focus, new future. Eur J Cancer 2007; 43:1895-904.
12. Morgillo F, Kim WY, Kim ES, et al. Implication of the insulin-like growth factor- IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib. Clin Cancer Res 2007; 13:2795-803.
13. Morgillo F, Woo JK, Kim ES, et al. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. Cancer Res 2006; 66:10100-11.
14. Gray SG, Stenfeldt Mathiasen I, De Meyts P. The insulin-like growth factors and insulin-signalling systems: an appealing target for breast cancer therapy? Horm Metab Res 2003; 35:857-71.
15. Hoang CD, Zhang X, Scott PD, et al. Selective activation of insulin receptor sub- strate-1 and -2 in pleural mesothelioma cells: association with distinct malignant phenotypes. Cancer Res 2004; 64:7479-85.
16. Koda M, Sulkowska M, Kanczuga-Koda L, et al. Expression of the insulin receptor substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with Bcl-xL and Bax proteins. Neoplasma 2005; 52:361-3.
17. Boissan M, Beurel E, Wendum D, et al. Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma. Am J Pathol 2005; 167:869-77.
18. Koda M, Sulkowska M, Kanczuga-Koda L, et al. Expression of insulin receptor substrate 1 in primary breast cancer and lymph node metastases. J Clin Pathol 2005; 58:645-9.
19. Cui X, Kim HJ, Kuiatse I, et al. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration. Cancer Res 2006; 66:5304-13.
20. Liao Y, Abel U, Grobholz R, et al. Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade. Hum Pathol 2005; 36:1186-96.
21. Han CH, Cho JY, Moon JT, et al. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Oncol Rep 2006; 16:1205-10.
22. Poulaki V, Qin W, Joussen AM, et al. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 2002; 109:805-15.
23. Miele C, Rochford JJ, Filippa N, et al. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 2000; 275:21695-702.
24. Bermont L, Lamielle F, Lorchel F, et al. Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. J Clin Endocrinol Metab 2001; 86:363-8.
25. Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006; 441:437-43.
26. Jiang ZY, He Z, King BL, et al. Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis. J Biol Chem 2003; 278:31964-71.
27. Grimm J, Sachs M, Britsch S, et al. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol 2001; 154:345-54.
28. Gray SG, De Meyts P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab Res Rev 2005; 21:416-33.
29. Leitlein J, Aulwurm S, Waltereit R, et al. Processing of immunosuppressive pro-TGF-beta 1,2 by human glioblastoma cells involves cytoplasmic and secreted furin-like proteases. J Immunol 2001; 166:7238-43.
30. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427-31.
31. Osada H, Tatematsu Y, Yatabe Y, et al. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene 2002; 21:2418-24.
32. Takahashi M, Papavero V, Yuhas J, et al. Altered expression of members of the IGF-axis in clear cell renal cell carcinoma. Int J Oncol 2005; 26:923-31.
33. Nagle JA, Ma Z, Byrne MA, et al. Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol Cell Biol 2004; 24:9726-35.
34. Chang Q, Li Y, White MF, et al. Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Res 2002; 62:6035-8.
35. Ehrlich M. Cancer-linked DNA hypomethylation and its relationship to hypermethylation. Curr Top Microbiol Immunol 2006; 310:251-74.
36. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006; 6:107-16.
37. Carrozza MJ, Utley RT, Workman JL, et al. The diverse functions of histone acetyltransferase complexes. Trends Genet 2003; 19:321-9.
38. Gray SG, Ekstrom TJ. The human histone deacetylase family. Exp Cell Res 2001; 262:75-83.
39. Swinson DE, Jones JL, Cox G, et al. Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 2004; 111:43-50.
40. Swinson DE, Jones JL, Richardson D, et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 2003; 21:473-82.
41. Garber K. Energy deregulation: licensing tumors to grow. Science 2006; 312:1158-9.
42. Wu C, Khan SA, Lange AJ. Regulation of glycolysis-role of insulin. Exp Gerontol 2005; 40:894-9.
43. Golshani S. Insulin, growth factors, and cancer cell energy metabolism: an hypothesis on oncogene action. Biochem Med Metab Biol 1992; 47:108-15.
44. Uchida M, Enomoto A, Fukuda T, et al. Dok-4 regulates GDNF-dependent neurite outgrowth through downstream activation of Rap1 and mitogen-activated protein kinase. J Cell Sci 2006; 119:3067-77.
45. Rao VN, Huebner K, Isobe M, et al. elk, tissue-specific ets-related genes on chromosomes X and 14 near translocation breakpoints. Science 1989; 244:66-70.